Immix Biopharma, Inc.
(IMMX - NASDAQ)
9,53 USD
📋 Profilo Aziendale

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia.

|